All recalls
Every recall from CPSC, FDA, USDA and NHTSA, newest first. Each one links to the agency's official notice. Looking for one product? Check a product.
16,208 recalls · page 288 of 325
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Azithromycin -15 ¿gThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Aztreonam - 30 ug¿There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Cefaclor - 30 ug¿There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Cefepime - 30 ug¿There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Cefixime - 5 ug¿There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Cefotaxime - 30 ug¿There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Cefpodoxime - 10 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Ceftaroline - 30 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Ceftazidime- 30 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Ceftriaxone- 30 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Cefuroxime- 30 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Chloramphenicol- 30 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Ciprofloxacin- 5 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Clarithromycin- 15 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Doripenem- 15 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Ertapenem- 10 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Imipenem- 10 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Levofloxacin- 5 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Meropenem- 10 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Minocycline - 30 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Moxifloxacin- 5 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Ofloxacin- 5 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Piperacillin/Tazobactam- 100/10 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Rifampin- 5 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Sulfamethoxazole with Trimethoprim 23.75/1.25 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Becton Dickinson & Co. recalls BD BBL Sensi Disc Tetracycline 30 ugThere is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.
-
Class IIofficial
Microbiologics Inc recalls Microbiologics Enteric Pathogens Control Panel (Inactivated Pellet)The negative control was contaminated with one of the positive control pathogens (Norovirus). This would result in users getting a positive call for Norovirus when running the negative control.
-
Class Iofficial
World Green Nutrition Inc. recalls ELV ALIPOTEC brand MEXICAN TEJOCOTE ROOT SUPPLEMENT PIECES (RAIZ DE TEJOCOTE MEXICANO SUPLEMENTO EN TROZOS)FDA analysis found product labeled as tejocote is actually contains yellow oleander, which is toxic to humans.
-
Class IIofficial
Lupin Pharmaceuticals Inc. recalls Rifampin Capsules USP 150mgSubpotent Drug and Failed Impurities/Degradation Specifications
-
Class IIofficial
Lupin Pharmaceuticals Inc. recalls Rifampin Capsules USP 300mgSubpotent Drug and Failed Impurities/Degradation Specifications
-
Class IIofficial
DeIorio Foods, Inc. recalls DeIorio FoodsProduct contains conveyor belt pieces.
-
Class IIofficial
Impulse Dynamics (usa) Inc recalls OPTIMIZER model CCM X11 implantable pulse generator (IPG) devices - Smart Mini and LiteOPTIMIZER devices may cease to deliver CCM therapy if the device incorrectly detects a charging error. This may cause patients to experience heart failure symptoms similar to before implantation of the device.
-
Class IIofficial
Olympus Corporation of the Americas recalls Hemostasis ProbeThe BICOAG Hemostasis Probe with a coaxial plug was mispackaged into the package and labeled as a BICOAG Hemostasis Probe with a fixed pin connector.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Fluocinolone Acetonide OilFailed Excipient Specifications: OOS for assay of Isopropyl Alcohol
-
Class Iofficial
Azurity Pharmaceuticals, Inc. recalls Zenzedi (Dextroamphetamine Sulfate) CII TabletsLabeling: Label Mix-up
-
Class IIofficial
Ventura Foods Llc recalls DELI CAROLINA STYLE MUSTARD BBQ SAUCEUndeclared fish (anchovy) allergen
-
Class IIofficial
Lidl US TRADING recalls Duc De Coeur Camembert Cheese Croquettes Frozen NET WT 9 OZ (256g) UPC 2023 8391 Packaged in a cardboard cartoPossible contamination with Listeria monocytogenes
-
Class Iofficial
U.S. Tov, Inc. recalls Dragonfly Jelly Bar Handbag 11.64ozPotential choking hazard; product contains konjac.
-
Class IIofficial
MEDLINE INDUSTRIES, LP - Northfield recalls Medline Contro-Bulb SyringePackaging material was updated for the Bulb Irrigation Syringe (DYND20125), and additional testing done at Medline Corporate indicated the potential for the sterile barrier to be breached during transportation. This only affects two lot numbers (96922110001 and 96923100001).
-
Class IIofficial
Lupin Pharmaceuticals Inc. recalls Cefixime for Oral Suspension 100mg/5mLFailed Impurities/Degradation Specifications
-
Class IIofficial
Tornier, Inc recalls Stryker Tornier Perform Reversed Glenoid Press-Fit Short Post Ti6AI4VThe incorrect device is contained in the labeled package.
-
Class Iofficial
Thoratec Corp. recalls 1. HeartMate Touch Communication SystemDue to software and controller systems that results in unexpected pump start or pump stop.
-
Class IIofficial
Philips North America recalls Achieva 1.5T. Model (REF) Numbers 781196The Quadrature Body Coil (QBC) seal adhesive may fail, creating sharp edges that may come in contact with patients. If the QBC seal becomes loose during the scanning process, the risk to the patient may include skin abrasions, bruises, lacerations, hair loss/entanglement, and tissue injury.
-
Class IIofficial
Philips North America recalls Achieva 1.5T Conversion. Model (REF) Numbers 781346The Quadrature Body Coil (QBC) seal adhesive may fail, creating sharp edges that may come in contact with patients. If the QBC seal becomes loose during the scanning process, the risk to the patient may include skin abrasions, bruises, lacerations, hair loss/entanglement, and tissue injury.
-
Class IIofficial
Philips North America recalls Achieva 1.5T Initial system. Model (REF) Numbers 781178.The Quadrature Body Coil (QBC) seal adhesive may fail, creating sharp edges that may come in contact with patients. If the QBC seal becomes loose during the scanning process, the risk to the patient may include skin abrasions, bruises, lacerations, hair loss/entanglement, and tissue injury.
-
Class IIofficial
Philips North America recalls Achieva 3.0T. Model. (REF) Numbers 781277The Quadrature Body Coil (QBC) seal adhesive may fail, creating sharp edges that may come in contact with patients. If the QBC seal becomes loose during the scanning process, the risk to the patient may include skin abrasions, bruises, lacerations, hair loss/entanglement, and tissue injury.
-
Class IIofficial
Philips North America recalls Achieva XR. Model (REF) Numbers 781153The Quadrature Body Coil (QBC) seal adhesive may fail, creating sharp edges that may come in contact with patients. If the QBC seal becomes loose during the scanning process, the risk to the patient may include skin abrasions, bruises, lacerations, hair loss/entanglement, and tissue injury.
-
Class IIofficial
Philips North America recalls Ingenia 1.5T CX. Model (REF) Numbers 781262The Quadrature Body Coil (QBC) seal adhesive may fail, creating sharp edges that may come in contact with patients. If the QBC seal becomes loose during the scanning process, the risk to the patient may include skin abrasions, bruises, lacerations, hair loss/entanglement, and tissue injury.
-
Class IIofficial
Philips North America recalls Ingenia 3.0T CX. Model (REF) Numbers 781271The Quadrature Body Coil (QBC) seal adhesive may fail, creating sharp edges that may come in contact with patients. If the QBC seal becomes loose during the scanning process, the risk to the patient may include skin abrasions, bruises, lacerations, hair loss/entanglement, and tissue injury.
-
Class IIofficial
Philips North America recalls Intera 1.5T Achieva Nova. Model (REF) Numbers 781172.The Quadrature Body Coil (QBC) seal adhesive may fail, creating sharp edges that may come in contact with patients. If the QBC seal becomes loose during the scanning process, the risk to the patient may include skin abrasions, bruises, lacerations, hair loss/entanglement, and tissue injury.